Featured
Want to learn more about Beginning with the End in Mind – Study Endpoints: Targeting Patient-Centered Outcomes? You've come to the right site!
プログラム委員会
-
Elektra Papadopoulos, MD, MPH Director, Patient Experience Data and Strategy
AbbVie, United States -
Linda S. Deal, MS Head of Patient-Centered Outcomes Measurement
Pfizer Inc., United States -
Dianne Kennedy, MPH, RPH Consumer Safety Officer, Study Endpoints and Label Development, CDER
FDA, United States -
Annabel Nixon, PHD PRO Consultant
Chilli Consultancy, United Kingdom -
James P. Stansbury, PHD, MPH Social Science Analyst, Division of Non-Prescription Clinical Evaluation, CDER
FDA, United States -
Ashley F. Slagle, PHD, MS Principal, Scientific and Regulatory Consulting
Aspen Consulting, LLC, United States -
Keith Wenzel Volunteer
DIA Study Endpoints Community, United States -
Jessica Voqui, PHARMD, MS Regulatory Review Officer, Study Endpoints and Labeling Development, CDER
FDA, United States
